Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Nov 14, 2024; 30(42): 4523-4531
Published online Nov 14, 2024. doi: 10.3748/wjg.v30.i42.4523
Table 1 Characteristics of the patients according to 28-day mortality
Characteristics
All (n = 178)
Survivors (n = 93)
Non-survivors (n = 85)
Statistic
P value
Age, years76.00 (67.00, 83.00)75.00 (63.00, 83.00)77.00 (68.00, 83.00)Z = -1.230.218
Male, n (%)108 (60.67)55 (59.14)53 (62.35)χ² = 0.190.661
Pre-existing diseases
Diabetes mellitus, n (%)56 (31.46)30 (32.26)26 (30.59)χ² = 0.060.811
Hyptertension, n (%)95 (53.37)46 (49.46)49 (57.65)χ² = 1.200.274
Coronary heart disease, n (%)40 (22.47)17 (18.28)23 (27.06)χ² = 1.960.161
Stroke, n (%)25 (14.04)16 (17.20)9 (10.59)χ² = 1.610.204
Principal pathology
Cardiovascular, n (%)16 (8.99)7 (7.53)9 (10.59)χ² = 0.510.476
Neurological, n (%)16 (8.99)10 (10.75)6 (7.06)χ² = 0.740.389
GI/pancreatic/liver, n (%)23 (12.92)14 (15.05)9 (10.59)χ² = 0.790.375
Pulmonary, n (%)76 (42.70)35 (37.63)41 (48.24)χ² = 2.040.153
Renal, n (%)13 (7.30)8 (8.60)5 (5.88)χ² = 0.490.486
Metabolic disorders, n (%)6 (3.37)3 (3.23)3 (3.53)χ² = 0.00> 0.999
Heart rate1, beats/minute98.47 ± 21.5597.96 ± 21.6599.02 ± 21.55t= -0.330.743
C-reactive protein1, mg/L64.63 (23.67, 138.11)54.43 (18.23, 144.60)82.74 (40.36, 132.42)Z = -1.190.235
Glucose1, mmol/L9.31 (7.08, 13.00)8.97 (7.11, 12.10)9.42 (7.00, 14.65)Z = -0.480.629
Albumin1, g/L28.20 (25.10, 32.03)28.90 (25.80, 32.90)27.20 (24.50, 29.30)Z = -2.730.006
Serum lactate1, mmol/L1.70 (1.20, 2.98)1.60 (0.90, 2.40)1.90 (1.30, 3.30)Z = -2.360.018
Procalcitonin1, ng/mL0.68 (0.20, 2.81)0.58 (0.18, 3.35)0.78 (0.29, 2.45)Z = -0.890.373
Sepsis, n (%)43 (24.16)21 (22.58)22 (25.88)χ² = 0.260.607
Abdominal surgery, n (%)25 (14.04)16 (17.20)9 (10.59)χ² = 1.610.204
Acute kidney injure, n (%)93 (52.25)39 (41.94)54 (63.53)χ² = 8.300.004
Mechanical ventilation, n (%)145 (81.46)63 (67.74)82 (96.47)χ² = 24.27< 0.001
Start EN within 48 hours, n (%)138 (77.53)73 (78.49)65 (76.47)χ² = 0.100.747
SOFA score2, points7.00 (5.00, 11.00)6.00 (4.00, 9.00)9.00 (6.00, 11.00)Z = -4.45< 0.001
SOFA score3, points11.00 (7.00, 15.00)8.00 (6.00, 11.00)14.00 (11.00, 16.00)Z = -8.28< 0.001
APACHE II score2, points19.00 (15.00, 24.00)18.00 (13.00, 22.00)21.00 (16.00, 25.00)Z = -2.380.017
APACHE II score3, points22.00 (17.00, 28.00)18.00 (14.00, 22.00)26.00 (23.00, 32.00)Z = -7.20< 0.001
AGI grade3, grade2.00 (2.00, 3.00)2.00 (1.00, 2.00)3.00 (2.00, 3.00)Z = -6.85< 0.001
GIDS2, points1.00 (0.00, 1.00)1.00 (0.00, 1.00)1.00 (0.00, 1.00)Z = -1.150.249
GIDS3, points2.00 (1.00, 2.00)1.00 (1.00, 2.00)2.00 (2.00, 3.00)Z = -6.90< 0.001
Table 2 Multivariate logistic regression analysis with 28-day mortality
Variables
Model 1
Model 2
P value
OR (95%CI)
P value
OR (95%CI)
Pre-existing disease-coronary heart disease0.1522.12 (0.76-5.92)0.1851.99 (0.72-5.53)
Principal pathology- Pulmonary0.1192.05 (0.83-5.05)0.1391.96 (0.80-4.76)
Albumin0.6090.98 (0.91-1.05)0.7330.99 (0.92-1.06)
Serum lactate0.3160.91 (0.77-1.09)0.2830.91 (0.76-1.08)
Mechanical ventilation0.1293.16 (0.72-13.95)0.1073.37 (0.77-14.77)
SOFA score1< 0.0011.32 (1.13-1.54)0.0011.29 (1.11-1.52)
APACHE II score10.0701.08 (0.99-1.18)0.0581.09 (1.00-1.18)
GIDS10.0042.01 (1.25-3.24)//
AGI grade1//0.0191.94 (1.12-3.38)
Table 3 Analysis of the receiver operating characteristic curve values of scoring systems in predicting 28-day mortality in critically ill patients
Scoring system
AUC
P value
95%CI
Cut-off value
Sensitivity (%)
Specificity (%)
YI
PV+ (%)
PV- (%)
GIDS10.785< 0.0010.720-0.8511.587.0667.740.54871.1585.14
AGI10.779< 0.0010.713-0.8452.569.4184.950.54480.8275.24
SOFA10.859< 0.0010.805-0.9139.587.0667.740.54871.1585.14
APACHE II10.812< 0.0010.749-0.87521.581.1870.970.52171.8880.49
SOFA + GIDS20.874< 0.0010.822-0.92711.588.2474.190.62475.7687.34
SOFA + AGI20.869< 0.0010.816-0.92112.585.8875.270.61276.0485.37
APACHE II + GIDS20.833< 0.0010.774-0.89223.581.1874.190.55474.1981.18
APACHE II + AGI20.831< 0.0010.771-0.89023.584.7169.890.54672.0083.33